Orchid Pharma, a leading pharmaceutical firm based in Chennai, has appointed Rajnish Rohatgi as the Chief Executive Officer of its new division, Orchid AMS. This strategic move aims to bolster the company’s focus on promoting the rational use of anti-infectives, with a significant impact on public health in India.
Rohatgi brings to Orchid AMS over 35 years of extensive experience in both B2C and B2B sectors, spanning consumer goods and healthcare industries. His illustrious career includes key roles at renowned organizations such as Unilever, Max Hospital, and Becton Dickinson, where he demonstrated exceptional leadership and strategic foresight.
Having consulted with Orchid Pharma in the previous fiscal year, Rohatgi played a pivotal role in crafting a distinctive business strategy aimed at penetrating the domestic formulations market with a specialized range of antibiotics. His strategic contributions and deep industry knowledge prompted Orchid Pharma to invite him to assume the CEO position, entrusting him with the task of establishing and steering the new division towards success.
Rohatgi expressed enthusiasm about his new role, highlighting Orchid Pharma’s growth trajectory in the pharmaceutical sector and emphasizing the division’s mission to promote the rational use of antibiotics. This initiative is poised not only to drive business growth but also to address critical public health concerns such as Anti-Microbial Resistance (AMR) in India.
Under his leadership, Orchid AMS is expected to leverage Rohatgi’s expertise in business development, innovation, and strategic management. His academic background from IIT Kanpur and IIM Calcutta further underscores his capability to drive impactful initiatives and navigate complex market landscapes.
Manish Dhanuka, Managing Director of Orchid Pharma, welcomed Rohatgi’s appointment, foreseeing a dynamic phase of growth and achievement for the company under his stewardship. The strategic alignment between Rohatgi’s vision and Orchid Pharma’s objectives sets a promising course for advancing healthcare solutions and fostering sustainable business practices in the pharmaceutical industry.